Remove Bioinformatics Remove Development Remove Gene Expression Remove Protein
article thumbnail

Democratising proteomics for cancer and beyond

Drug Discovery World

DDW Editor Reece Armstrong speaks to Nautilus Co-Founder and Chief Scientist Parag Mallick , about the company’s recent collaboration which aims to uncover the proteins that could be behind a rare and fatal childhood cancer. To do this, Nautilus will useits protein analysis platform to provide TGen with data on the proteins involved in DPIG.

Protein 52
article thumbnail

How big data analytics can make personalised care a reality

Drug Discovery World

Johannes Goll, Global Head of Emmes’ Biomedical Data Science and Bioinformatics department, explains how big data analytics can deliver improved therapies and bring clinical research one step close to realising the potential of personalised care. Figure 2: Advanced data visualisation examples for transcriptomics data.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Synthetic biology tools advancing and accelerating drug discovery efforts

Drug Discovery World

Known for its ability to offer precision and flexibility while expanding the experimental scale, synthetic biology tools can reduce development timelines and costs, and lend a competitive advantage over traditional methods. . Here we outline four synthetic biology approaches that are improving and accelerating drug discovery: .

DNA 98
article thumbnail

What to expect from SLAS Europe 2023

Drug Discovery World

BMG LABTECH develops and manufactures innovative, high- quality, and reliable microplate reader instrumentation, while Microtechnix (MTX) is a company providing innovative solutions for biological laboratory assays. On the other hand, Bionomous provide AI-powered solutions for screening, sorting and dispensing of small biological entities.

Doctors 52